臺灣博碩士論文加值系統

α-Tomatine 是從茄科番茄屬植物番茄（Lycopersicon esculentum）中萃取出來的純化物，已經有研究文獻指出 α-tomatine 具有抗菌的作用，包括多種的真菌以及人類的病原菌。近年來，有文獻指出 α-tomatine 在直腸癌以及肝癌細胞上都具有抑制生長效果，但目前機轉卻依然不明。因此，本實驗的主旨便是評估 α-tomatine在 in vivo以及in vitro對於血癌的治療效果。藉由 MTT assay（3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide）的方法來評估 α-tomatine 對於 HL60 及 K562 細胞增生的影響，發現給予 α-tomatine 24 小時之後具有濃度相關性抑制細胞生長作用，於HL60 及 K562 的 IC50 分別是1.92 μM 和1.51 μM 。而不論是 HL60 或是 K562 ，給予 α-tomatine 之後，其細胞週期並無顯著的改變，並且 α-tomatine 在兩株細胞中皆非經由 caspase 的活化來造成細胞死亡。然而，α-tomatine 卻能有效地抑制 survivin 的表現以及促進 AIF 進入細胞核。此外，給予α-tomatine之後會影響粒線體膜電位的改變、促進Bak的活化以及增加 Mcl-1 short form（Mcl-1s）的表現。實驗更進一步證實，在 HL60 的異位移植動物模式中，α-tomatine （5 mg/Kg）可以有效的抑制腫瘤生長且不影響小鼠的體重。利用免疫組織染色及西方點墨法，在給予 α-tomatine 的組織中，也的確能看到 survivin表現量較低。綜合以上結果，我們得知 α-tomatine藉由活化Bak及Mcl-1s，造成細胞粒線體膜電位的改變，因而促進 AIF 進核，同時也會抑制 survivin的表現，但卻不經由影響細胞週期以及活化 caspase 的路徑來造成細胞凋亡，所以 α-tomatine 具有潛力發展成新的抗血癌藥物。

α-Tomatine, a tomato glycoalkaloid, has been reported to possess antibiotic properties against a variety of fungi and human pathogens. It also inhibited the growth of human colon and liver cancer cells. Although α-tomatine has been displayed anticancer activity in the previous studies, the mechanism of action remains unclearly. In this study, we evalulate the therapeutic potential of α-tomatine against leukemia cells in vitro and in vivo. Inhibition of cell proliferation is determined by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide （MTT） assay. In this assay, it shows an IC50 of 1.92 μM and 1.51 μM, in HL60 and K562, respectively, after 24 hours of treatment. Neither in HL60 nor K562 cells, the distribution of cell cycle does change using flow cytometry. By Western blotting, we also find that α-tomatine induces cell death independent on caspase activation in both cell lines. Nevertheless, pro-apoptotic protein survivin expression is obviously down-regulated, after α-tomatine treatment. α-Tomatine also triggers apoptosis inducing factor（AIF） into the nucleus. Moreover, α-tomatine can lead to lose the mitochrondrial membrane potential, and activate Bak and Mcl-1 short form（Mcl-1s）protein level. Furthermore, α-tomatine（5 mg/kg）can significantly inhibit tumor xenograft growth and doesn’t affect the body weight of mice. Then, tumors were analyzed for survivin alterations
3
by immunohistochemistry and immunoblotting. Indeed, α-tomatine can decrease survivin protein level in the tumors. Taken together, our findings indicate that α-tomatine can increase the activation of Bak or Mcl-1s, leading to lose mitochondrial membrane poptential and induction of AIF translocation to the nulceus. Meanwhile, α-tomatine can also inhibit survivin and cause apoptosis by cell cycle- and capase-independent pathway. All these findings suggest that α-tomatine could be served as a new candidate in leukemia cancer treatment.

縮寫表...................................................................
1
中文摘要...............................................................
2
英文摘要...............................................................
3
第一章 緒論..........................................................
5
第二章 文獻回顧..................................................
7
第三章 實驗材料與方法......................................
30
第四章 結果..........................................................
37
第五章 討論..........................................................
42
第六章 結論與展望..............................................
48
參考文獻................................................................
64
著作........................................................................
75

Abraham, MC, Shaham, S (2004) Death without caspases, caspases without death. Trends Cell Biol 14(4): 184-193.
Alnemri, ES, Livingston, DJ, Nicholson, DW, Salvesen, G, Thornberry, NA, Wong, WW, Yuan, J (1996) Human ICE/CED-3 protease nomenclature. Cell 87(2): 171.
Altieri, DC (2003) Blocking survivin to kill cancer cells. Methods Mol Biol 223(34): 533-542.
Altieri, DC (2008) New wirings in the survivin networks. Oncogene 27(48): 6276-6284.
Altieri, DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8(1): 61-70.
Ambrosini, G, Adida, C, Altieri, DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8): 917-921.
Bae, J, Leo, CP, Hsu, SY, Hsueh, AJ (2000) MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem 275(33): 25255-25261.
Bennett, JM, Catovsky, D, Daniel, MT, Flandrin, G, Galton, DA, Gralnick, HR, Sultan, C (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33(4): 451-458.
Brand, TC, Tolcher, AW (2006) Management of high risk metastatic prostate cancer: 64
the case for novel therapies. J Urol 176(6 Pt 2): S76-80; discussion S81-72.
Brunelle, JK, Letai, A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122(Pt 4): 437-441.
Cande, C, Cohen, I, Daugas, E, Ravagnan, L, Larochette, N, Zamzami, N, Kroemer, G (2002) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84(2-3): 215-222.
Carter, B, Andreeff, M (2008) Targeting survivin in leukemia. Oncology review 1: 195-204.
Carter, BZ, Kornblau, SM, Tsao, T, Wang, RY, Schober, WD, Milella, M, Sung, HG, Reed, JC, Andreeff, M (2003) Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood 102(12): 4179-4186.
Cauwels, A, Janssen, B, Waeytens, A, Cuvelier, C, Brouckaert, P (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 4(4): 387-393.
Cerretti, DP, Kozlosky, CJ, Mosley, B, Nelson, N, Van Ness, K, Greenstreet, TA, March, CJ, Kronheim, SR, Druck, T, Cannizzaro, LA, et al. (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256(5053): 97-100.
Chandele, A, Prasad, V, Jagtap, JC, Shukla, R, Shastry, PR (2004) Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia 6(1): 29-40.
Chang, CC, Heller, JD, Kuo, J, Huang, RC (2004) Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. Proc Natl Acad Sci U S A 101(36): 13239-13244.
65
Croci, DO, Cogno, IS, Vittar, NB, Salvatierra, E, Trajtenberg, F, Podhajcer, OL, Osinaga, E, Rabinovich, GA, Rivarola, VA (2008) Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway. J Cell Biochem 105(2): 381-390.
Daugas, E, Nochy, D, Ravagnan, L, Loeffler, M, Susin, SA, Zamzami, N, Kroemer, G (2000) Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476(3): 118-123.
Donovan, M, Cotter, TG (2004) Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 1644(2-3): 133-147.
Elangovan, S, Hsieh, TC (2008) Control of cellular redox status and upregulation of quinone reductase NQO1 via Nrf2 activation by alpha-lipoic acid in human leukemia HL-60 cells. Int J Oncol 33(4): 833-838.
Fausel, CA (2006) Novel treatment strategies for chronic myeloid leukemia. Am J Health Syst Pharm 63(23 Suppl 8): S15-20; quiz S21-12.
Fortugno, P, Beltrami, E, Plescia, J, Fontana, J, Pradhan, D, Marchisio, PC, Sessa, WC, Altieri, DC (2003) Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A 100(24): 13791-13796.
Friedman, M (2002) Tomato glycoalkaloids: role in the plant and in the diet. J Agric Food Chem 50(21): 5751-5780.
Friedman, M, McQuistan, T, Hendricks, JD, Pereira, C, Bailey, GS (2007) Protective effect of dietary tomatine against dibenzo[a,l]pyrene (DBP)-induced liver and 66
stomach tumors in rainbow trout. Mol Nutr Food Res 51(12): 1485-1491.
Fukuda, S, Pelus, LM (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5(5): 1087-1098.
Gritsko, T, Williams, A, Turkson, J, Kaneko, S, Bowman, T, Huang, M, Nam, S, Eweis, I, Diaz, N, Sullivan, D, Yoder, S, Enkemann, S, Eschrich, S, Lee, JH, Beam, CA, Cheng, J, Minton, S, Muro-Cacho, CA, Jove, R (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12(1): 11-19.
Gurbuxani, S, Xu, Y, Keerthivasan, G, Wickrema, A, Crispino, JD (2005) Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci U S A 102(32): 11480-11485.
Gyurkocza, B, Plescia, J, Raskett, CM, Garlick, DS, Lowry, PA, Carter, BZ, Andreeff, M, Meli, M, Colombo, G, Altieri, DC (2006) Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors. J Natl Cancer Inst 98(15): 1068-1077.
Harralson, JD, van Nagell, JR, Jr., Roddick, JW, Jr., Sprague, AD (1974) The effect of prophylactic antibiotics on pelvic infection following vaginal hysterectomy. Am J Obstet Gynecol 120(8): 1046-1049.
Hegde, R, Srinivasula, SM, Zhang, Z, Wassell, R, Mukattash, R, Cilenti, L, DuBois, G, Lazebnik, Y, Zervos, AS, Fernandes-Alnemri, T, Alnemri, ES (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 277(1): 432-438.
Huang, DM, Shen, YC, Wu, C, Huang, YT, Kung, FL, Teng, CM, Guh, JH (2004) Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells. Eur J Pharmacol 503(1-3): 17-24.
67
Iwasaki, R, Ito, K, Ishida, T, Hamanoue, M, Adachi, S, Watanabe, T, Sato, Y (2009) Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci 100(2): 349-356.
Jaattela, M, Tschopp, J (2003) Caspase-independent cell death in T lymphocytes. Nat Immunol 4(5): 416-423.
Kang, MH, Reynolds, CP (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15(4): 1126-1132.
Kerr, JF, Wyllie, AH, Currie, AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4): 239-257.
Kim, R, Tanabe, K, Uchida, Y, Emi, M, Inoue, H, Toge, T (2002) Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 50(5): 343-352.
Koda-Kimble. Applied Therapeutics the Clinical Use of Drugs.8/e
Kroemer, G, Martin, SJ (2005) Caspase-independent cell death. Nat Med 11(7): 725-730.
LaCasse, EC, Baird, S, Korneluk, RG, MacKenzie, AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17(25): 3247-3259.
Lee, KR, Kozukue, N, Han, JS, Park, JH, Chang, EY, Baek, EJ, Chang, JS, Friedman, M (2004) Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. J Agric Food Chem 52(10): 2832-2839.
68
Lens, SM, Wolthuis, RM, Klompmaker, R, Kauw, J, Agami, R, Brummelkamp, T, Kops, G, Medema, RH (2003) Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J 22(12): 2934-2947.
Li, LY, Luo, X, Wang, X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412(6842): 95-99.
Li, PF, Dietz, R, von Harsdorf, R (1997) Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96(10): 3602-3609.
Li, S, Zhao, Y, He, X, Kim, TH, Kuharsky, DK, Rabinowich, H, Chen, J, Du, C, Yin, XM (2002) Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem 277(30): 26912-26920.
Liu, T, Brouha, B, Grossman, D (2004) Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 23(1): 39-48.
Liu, X, Kim, CN, Yang, J, Jemmerson, R, Wang, X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1): 147-157.
Loeffler, M, Daugas, E, Susin, SA, Zamzami, N, Metivier, D, Nieminen, AL, Brothers, G, Penninger, JM, Kroemer, G (2001) Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 15(3): 758-767.
Luo, X, Budihardjo, I, Zou, H, Slaughter, C, Wang, X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94(4): 481-490.
69
Luthi, AU, Martin, SJ (2007) The CASBAH: a searchable database of caspase substrates. Cell Death Differ 14(4): 641-650.
Majno, G, Joris, I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146(1): 3-15.
Marioni, G, Bertolin, A, Giacomelli, L, Marchese-Ragona, R, Savastano, M, Calgaro, N, Marino, F, De Filippis, C, Staffieri, A (2006) Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis. Anticancer Res 26(5B): 3813-3817.
Mesri, M, Morales-Ruiz, M, Ackermann, EJ, Bennett, CF, Pober, JS, Sessa, WC, Altieri, DC (2001) Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 158(5): 1757-1765.
Miramar, MD, Costantini, P, Ravagnan, L, Saraiva, LM, Haouzi, D, Brothers, G, Penninger, JM, Peleato, ML, Kroemer, G, Susin, SA (2001) NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 276(19): 16391-16398.
Mitsiades, CS, Mitsiades, N, Poulaki, V, Schlossman, R, Akiyama, M, Chauhan, D, Hideshima, T, Treon, SP, Munshi, NC, Richardson, PG, Anderson, KC (2002) Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 21(37): 5673-5683.
Miura, M, Zhu, H, Rotello, R, Hartwieg, EA, Yuan, J (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75(4): 653-660.
Nakahara, T, Takeuchi, M, Kinoyama, I, Minematsu, T, Shirasuna, K, Matsuhisa, A, Kita, A, Tominaga, F, Yamanaka, K, Kudoh, M, Sasamata, M (2007) YM155, a novel
70
small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67(17): 8014-8021.
Nishie, K, Gumbmann, M. R, Keyl, A. C (1971) Pharmacology of solanine. Toxical. Appl. Pharmacol 19(1): 81-92.
Perfettini, JL, Kroemer, G (2003) Caspase activation is not death. Nat Immunol 4(4): 308-310.
Philchenkov, A, Zavelevich, M, Kroczak, TJ, Los, M (2004) Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 26(2): 82-97.
Qin, H, Srinivasula, SM, Wu, G, Fernandes-Alnemri, T, Alnemri, ES, Shi, Y (1999) Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399(6736): 549-557.
Rugo, H, Shtivelman, E, Perez, A, Vogel, C, Franco, S, Tan Chiu, E, Melisko, M, Tagliaferri, M, Cohen, I, Shoemaker, M, Tran, Z, Tripathy, D (2007) Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat 105(1): 17-28.
Sackmann, W, Kern, H, Wiesmann, E (1959) Studies on the biological effects of solanine and tomatine. Schweiz. Z. Allg. Pathol. Bacteriol 22: 557-563.
Sandrock, RW, Vanetten, HD (1998) Fungal Sensitivity to and Enzymatic Degradation of the Phytoanticipin alpha-Tomatine. Phytopathology 88(2): 137-143.
Shin, S, Sung, BJ, Cho, YS, Kim, HJ, Ha, NC, Hwang, JI, Chung, CW, Jung, YK, Oh, BH (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40(4): 1117-1123.
71
Skoufias, DA, Mollinari, C, Lacroix, FB, Margolis, RL (2000) Human survivin is a kinetochore-associated passenger protein. J Cell Biol 151(7): 1575-1582.
Susin, SA, Lorenzo, HK, Zamzami, N, Marzo, I, Snow, BE, Brothers, GM, Mangion, J, Jacotot, E, Costantini, P, Loeffler, M, Larochette, N, Goodlett, DR, Aebersold, R, Siderovski, DP, Penninger, JM, Kroemer, G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397(6718): 441-446.
Suzuki, Y, Imai, Y, Nakayama, H, Takahashi, K, Takio, K, Takahashi, R (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8(3): 613-621.
Tamm, I, Wang, Y, Sausville, E, Scudiero, DA, Vigna, N, Oltersdorf, T, Reed, JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58(23): 5315-5320.
Thornberry, NA, Bull, HG, Calaycay, JR, Chapman, KT, Howard, AD, Kostura, MJ, Miller, DK, Molineaux, SM, Weidner, JR, Aunins, J, et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356(6372): 768-774.
van Engeland, M, Nieland, LJ, Ramaekers, FC, Schutte, B, Reutelingsperger, CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1): 1-9.
van Engeland, M, Ramaekers, FC, Schutte, B, Reutelingsperger, CP (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24(2): 131-139.
Verhagen, AM, Vaux, DL (2002) Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7(2): 163-166.
72
Wang, M, Zhang, L, Han, X, Yang, J, Qian, J, Hong, S, Samaniego, F, Romaguera, J, Yi, Q (2007) Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 109(12): 5455-5462.
Wang, ZY, Chen, Z (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111(5): 2505-2515.
Widlak, P, Li, LY, Wang, X, Garrard, WT (2001) Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J Biol Chem 276(51): 48404-48409.
Willis, SN, Chen, L, Dewson, G, Wei, A, Naik, E, Fletcher, JI, Adams, JM, Huang, DC (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19(11): 1294-1305.
Wrzesien-Kus, A, Smolewski, P, Sobczak-Pluta, A, Wierzbowska, A, Robak, T (2004) The inhibitor of apoptosis protein family and its antagonists in acute leukemias. Apoptosis 9(6): 705-715.
Wyllie, AH, Kerr, JF, Currie, AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306.
Xing, Z, Conway, EM, Kang, C, Winoto, A (2004) Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 199(1): 69-80.
Yang, YW, Sheikh, NA, Morrow, WJ (2002) The ultrastructure of tomatine adjuvant. Biomaterials 23(23): 4677-4686.
Yu, SW, Wang, H, Poitras, MF, Coombs, C, Bowers, WJ, Federoff, HJ, Poirier, GG,
73
Dawson, TM, Dawson, VL (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297(5579): 259-263.
Zou, H, Henzel, WJ, Liu, X, Lutschg, A, Wang, X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90(3): 405-413.
74